Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study
Background: Interleukin-18 (IL-18) is involved in endothelial activation and dysfunction, and in the pathogenesis and severity of acute graft-versus-host disease (aGVHD). Its relevance for patient outcome after allogeneic stem cell transplantation (alloSCT) has not yet been comprehensively addressed...
Main Authors: | Aleksandar Radujkovic, Lambros Kordelas, Hao Dai, David Schult, Joshua Majer-Lauterbach, Dietrich Beelen, Carsten Müller-Tidow, Peter Dreger, Thomas Luft |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-11-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419306887 |
Similar Items
-
Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation
by: Aleksandar Radujkovic, et al.
Published: (2020-09-01) -
The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease
by: Lambros Kordelas, et al.
Published: (2016-10-01) -
Low Soluble Programmed Cell Death Protein 1 Levels After Allogeneic Stem Cell Transplantation Predict Moderate or Severe Chronic GvHD and Inferior Overall Survival
by: Lambros Kordelas, et al.
Published: (2021-09-01) -
Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival
by: Lambros Kordelas, et al.
Published: (2020-01-01) -
Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD
by: Hao Dai, et al.
Published: (2021-02-01)